We investigated theimmunoprecipitation of apolipoprotein Bbinding lipoproteins, orofapo A-I-and apo C-bindinglipoproteins, by delipidated antiserumformeasuring cholesterol in the nonprecipitated lipoprotein fractions. After immunoprecipitation of serum withdelipidated ariti-apo B, we determined by immunoelectrophoresis that no /3-or pre-f3 lipoproteins were present, whereas a-lipoproteins remained in the supernate.Conversely,afterimmunoprecipitation with an antiserumagainstapo A-I+ apo C, only lipoproteins with /3-mobility were detectedand no apo B from f3-lipoproteins was in the precipitate. The concentration of cholesterol in the supernate after immunoprecipitation with anti-apo B correlated highly (r 0.93, n = 118) with cholesterol measured after precipitation with phosphotungstic acid/MgCI2. The cholesterol concentration after immunoprecipitation with anti-apo A-I and anti-apo C correlated similarly well (r = 0.94, n = 145) with the LDL-cholesterol calculated by Friedewald's formula in serum specimens reflecting moderate hyperlipoproteine- fractions of human plasma or serum is routinely used for the differential diagnosis ofdyslipoproteinemia and the evaluationofrisk for cardiovascular disease. The reference method for the separation oflipoproteins isultracentrifugation (1) or ultracentrifugation combined with precipitation with polyanion (2). For normolipemic and moderate hyperlipoproteinemic serum, polyanionprecipitation alone isthe most common method offractionation (3-5).
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precipitation with polyanion compared
Measurement of cholesterol in lipoprotein fractions of human plasma or serum is routinely used for the differential diagnosis ofdyslipoproteinemia and the evaluationofrisk for cardiovascular disease. The reference method for the separation oflipoproteins isultracentrifugation (1) or ultracentrifugation combined with precipitation with polyanion (2) . For normolipemic and moderate hyperlipoproteinemic serum, polyanionprecipitation alone isthe most common method offractionation (3) (4) (5) .
Also, electrophoretic separation in agarose with subsequent polyanion precipitation for densitometry (6) , for quantification of cholesterol in lipoprotern fractions by gas-liquid chromatography (7) or by enzymic determination (8), has been described.
Apolipoprotein (apo) B is the major protein constituent in low-density (LDL) and very-low-density lipoproteins (VLDL) (9), whereas apo A-I and apo C are predominantly bound to high-density lipoproteins (HDL) and VLDL.3 The hydrated densities of the three major lipoprotein classes are closely related to the distribution of these peptides. Some investigators, however, have also detected apo B in HDL (10) and apo A-I in LDL (11).
Immunoprecipitation has been claimed to successfully separate subfractions of major lipoprotein classes (12) 
Materials and Methods
Materials
Antisera against human apo B (lot no. 3766), ape A-I (lot no.8857),and ape A-il(lot no.4046) were purchased from Behringwerke AG, Marburg, F.R.G. as was Lipoclean#{174} (perfluoroperchloroethylene).
Reagents for cholesterol and triglyceridedetermination and the phosphotungstic acid/MgCl2 reagentforprecipitation ofVLDL and LDL were obtainedfrom Boehringer Mannheim GmbH, Mannheim, 
Procedures
General assay procedure.
We routinely measured triglyceride and cholesterol in the serum samples by enzymic analysis (13, 14) and by the chemical method of the Lipid Research Clinics (2). HDL-cholesterol was measured enzymically after precipitation of VLDL and LDL with phosphotungstic acidlMgCl2 (3) . LDL-cholesterol concentrations in serum were calculated by the formula of Friedewald et al.
(15).
HDL was isolated from human serum by ultracentrifugation, as described by Havel et al. (1) . Ape B was measured by immunonephelometry of 30 L of the supernate after immunoprecipitation with 200 L of anti-apo B as previously described (16) .
Isolation of apolipoprotein
and the production of antiserum. Ape A-I and ape C peptides from HDL and VLDL were purified as described in detailelsewhere (17) . We injected subcutaneously intorabbits 0.3mg ofpurified apo A-Imixed with Freund's adjuvant. Other animals were immunized with a mixture of ape C-I, C-Il, C-rn or a mixture of ape A-I + ape C-I, C-H, C-HI. At two-to three-week intervals we administered booster injections of the antigen mixture in incomplete Freund's adjuvant. Ten days after the fourth injection the animals were bled for the isolation of antiserum. Testing with immunoelectrophoresis and immunodiffusion (18) showed that the various antisera reacted against ape A-I, ape C-Ill2, C-ffl1, C-Ill0, and ape C-il, but not against ape C-I, ape B, or human serum albumin. Serum from animals immunized with ape A-I reacted only with apo A-I. Immunization with a mixture of ape C-I, C-il, C-rn produced immunoreactivity against ape C-Il and ape C-rn, but not against ape C-I. Method A: We mixed 1 mL of rabbit antiserum against human ape B for 10 mm at room temperature with 0.1 g of controlled-pore glass (solid phase). After centrifugation for 10 mm at 30 000 x g at room temperature, we mixed the supernate with controlled-pore glass, as above. The resulting concentration of cholesterol in the antiserum was 50 molJL. We diluted this delipidated antiserum with an equal volume of isotonic saline and used this as the immunoprecipitant.
Method B: We vigorously mixed 1 mL of antiserum against ape A-I and ape C with 2.5 mL of Lipeclean and nhexylanune (95/5 by vol) at room temperature for 15 mm.
After centrifugation at 13 000 x g for 5 mm, we removed the upper phase by pipetting to extract its lipids by this same procedure two more times. For routine analysis we used this delipidated antiserum after diluting it threefold with isotonic saline. This dilution, which contained 50 pmol of cholesterol per liter, was used as the immunoprecipitant.
In alternative experiments we extracted the lipids with Lipeclean and n-hexanol or octanol (75/25 by vol).
Immunoprecipitation of lipoproteins.
We mixed 10,20,30, or 40 L of fresh human serum with 100 uL of diluted delipidated antiserum to apo B, anti-ape A-I, or a mixture of anti-ape A-I + ape C. After letting the mixture stand for 1 h at room temperature, we centrifuged the immunocomplexes for 10 mm at 15000 x g. For routine measurements we economized by using only 10 L of serum with 50 L of the diluted delipidated anti-apo B, or 5 L of serum with 50 L of antiserum against ape A-I + ape C. We measured the cholesterol concentrations in the supernates enzymically.
Immunoelectrophoresis studies.
After immunoprecipitation we subjected 10 uL of the supernates to immunoelectrophoresis in agarose as previously described (18), using antisera against ape B, ape C, ape A-I, and ape A-il to detect lipoproteins.
The lipids in the immunoprecipitates were stained with Sudan black (19) . In additional experiments we washed the precipitates from the reaction with anti-ape A-I and anti-ape C twice with 0.5 mL of isotonic saline, then dissolved the precipitates in 20 jxL of urea solution (6 mol/L of Ti-is HC1 buffer, 0.1 mol/L, pH 9.6) and checked their immunoreactivity against ape A-I and ape B by immunoelectrophoresis.
Precision studies. To determine the precision of the method, we measured the cholesterol in a series of 10 supernates after immunoprecipitation and daily in eight aliquots of a serum with normal cholesterol and of anotherserum with a high cholesterol concentration.
Calculations.
We calculated residual cholesterol in human serum as the difference between the cholesterol in the supernate after immunoprecipitation and that in the antiserum as determined after delipidation, then multiplied this value by the dilution factor.
Results
Delipidation
Determination of lipids in serum supernates after selective immunoprecipitation of lipeproteins is suitable only when an antiserum free of lipids is the precipitating reagent. Lipids can be extracted with a liquid-liquid system or a solid-liquid system. On the basis of previous observations (20, 21), we tested several liquid-liquid systems for this. Adding n-hexylamine to Lipoclean extracts the cholesterol from rabbit antiserum more effectively than does the halogen carbon alone (Table 1) . To improve delipidation, we repeat the extraction step twice so that only small amounts of chn1sterol are detectable. This remaining pertion seems to be tightly bound to the protein moiety, such that addition- (Figure 1, left) . The immunoprecipitates from serum stained positive for lipids when anti-apo A-H, anti-ape B, and anti-ape C were used; the supernate stained for lipid in the /3-region when reacted with anti-apo B, but no lipid was stained in the a-region when reacted with antiape A-il or anti-ape A-I. Lipid-stained immunocomplexes with anti-ape C were also observed in the pre-f3 region with serum samples but not in the serum supernates after immunoprecipitation.
The 
Cop recipitation iudies.
To verif' the possibility of coprecipitation, we added increasing volumes of human H])L (isolated by ultracentrifugation) to the serum samples before immunoprecipitation with anti-ape B. The results did not indicate coprecipitation of HDL with precipitated LDL ( Free Anti-Apo B ape B, we immunoprecipitated a type Ha serum (triglyceride 0.5 mmolfL, cholesterol 11.4 mmol/L, LDL-cholesterol 9.7 mmolJL) with anti-ape A-I and anti-ape C. When we washed the immunoprecipitate with isotonic saline before immunoelectrophoresis, only anti-ape A-I caused a reaction; no precipitate was visible with antiape B (not shown).
Comparison Studies
These observations stimulated us to compare the immu- 
Precision Studies
The coefficient of variation (CV) for determinations with anti-ape A-I and anti-ape C for a series of 10 aliquots of a hyperlipidemic serum (cholesterol 1.62 mmoIJL, triglyceride 1.94 mmol/l) was 3.8%. The CV was 5.5% for estimations with a normolipemic serum (cholesterol 7.3 mmoIJL, triglyceride 1.6 mmoIJL) stored at 4#{176}C over eight consecutive days and 8.1% for the hyperlipidemic serum sample. Precision decreased for samples stored longer.
The CV for a series for cholesterol determinations in supernates after immunoprecipitation with anti-ape B of serum (triglyceride 1.2 mmollL, cholesterol 4.2 mmol/L) was 5.0%. The CV was 8.2% in a daily series of determinations over eight days after storage at 4 #{176}C (cholesterol concentration after immunoprecipitation, 0.94 mmol/L).
Discussion
The fractionation of lipeproteins by immunoafilnity chromatography and immunoprecipitation was successfully applied to isolate subclasses of lipeproteins (12, 23, 24) . To ape A-I, whereas the distribution of ape A-il varies considerably and may not be detectable in certain HDL subclasses Small amounts of the ape A peptides are also detectable in VLDL and in LDL (11) . The major protein constituents in VLDL are the ape C peptides and ape B. Ape C is also found in HDL. On the other hand, ape B composes approximately 85 to 95% of the LDL protein, and is also detectable in HDL subclasses (10) . The heterogeneous cornpesition of the apelipoprotein moieties in the different lipeprotein classes indicates that the cholesterol concentration in the supernate after immunoprecipitation with antiape B need not correspond to the concentration of cholesterol after lipeprotein precipitation with pelyanions. This is also true of the cholesterol measurement after immunoprecipitation with anti-ape A-I and anti-ape C in comparison with LDL-cholesterol determinations by ultracentrifugation or by the Friedewald formula.
Our studies indicate a selective immunoprecipitation of ape B-carrying lipeproteins. We did not observe incomplete Several studies demonstrate considerable variations in the precipitation of ape B-carrying lipeproteins by pelyanions (24, 25) . Recent investigations suggest that the treatment of serum with polyanions and divalent cations may not precipitate only VLDL and LDL, but also small amounts of HDL (26) (27) (28) . Therefore, the slight divergence of cholesterol concentration after immunoprecipitation and polyanion precipitation may reflect the nonidentity of the mechanism of the two reactions. Interestingly, the correlation between the methods compared is as good as that for the HDL-cholesterol determination after precipitation of VLDL and LDL with use of different polyanions (26) . The immunoelectrophoresis studies also confirm the efficacy of the iminunoprecipitation of lipeproteins carrying ape A-I and ape C. Thus, either the proportion of the /3-lipeproteins with a heterogeneous composition of apelipeproteins is small enough to be within the precision of the photometric determination of cholesterol in the supernatant f3-lipeprotein fraction, or the accessibility of antigenic binding sites in ape A-I and ape C bound to LDL may differ from that of the apelipeproteins bound to VLDL and HDL.
The quality of the antiserum undeniably limits its applicability. We are well aware of the limitations of our present immunoreagent. Therefore, we confined our studies to serum specimens without pronounced hypertriglyceridemia. The quality of the reagent is, however, sufficient for analysis of 85 to 90% of the serum specimens received by a routine laboratory.
Our efforts have concentrated on the production of an antiserum with a greater immunoreactivity against ape C peptides, which would extend the range of analysis to serum samples exhibiting an even higher degree of hyperlipidemia. In our experience, the described method offers several advantages: only very small sample volumes are required, and, in contrast to the pelyanion procedure, results are less susceptible to external influences, thereby allowing a direct determination of cholesterol equivalent to LDL-cholesterol.
